KoreaTimes - Bio

The Korea Times

The Korea Times

The Korea Times

Business

Bio

Mon, December 11, 2023 | 04:42

Samsung Biologics surpasses 3 tril. won in annual orders for 1st time

Samsung Biologics surpasses 3 tril. won in annual orders for 1st time

Samsung Biologics has surpassed 3 trillion won ($2.3 billion) in accumulated annual orders with its contract development and manufacturing organization (CDMO) drug manufacturing business thanks to a recent large-scale contract with an Asia-based pharmaceutical company, according to the drugmaker, Tuesday.

2023-11-28 15:25

CHA Bio's forum explores potential of cell, gene therapy

CHA Bio's forum explores potential of cell, gene therapy

CHA Medical and Bio Group hosted a forum featuring international researchers in the field of cell and gene therapy (CGT) to share the latest research findings and discuss the potential of CGT to treat rare and intractable diseases, the bio group said Friday.

2023-10-27 15:28

Samsung Biologics raises sales forecast on higher utilization of new plant

Samsung Biologics raises sales forecast on higher utilization of new plant

Samsung Biologics raised its sales forecast for 2023 to more than 20 percent from between 15 percent and 20 percent thanks to the increased use of its new factory Plant 4, the drug manufacturer said Wednesday.

2023-10-04 16:51

Samsung Biologics inks $242 mil. CMO deal with BMS

Samsung Biologics inks $242 mil. CMO deal with BMS

Samsung Biologics signed a $242 million contract manufacturing organization (CMO) deal with global pharmaceutical giant Bristol-Myers Squibb for the production of immuno-oncology drugs, the drug manufacturer said Monday. Samsung said the production agreement was made with BMS' subsidiary Swords Laboratories. Under the contract, its Plant 4 will serve as the production base fo...

Baek Byung-yeul | 2023-09-18 16:35

Lotte Healthcare launches digital health care platform CAZZLE

Lotte Healthcare launches digital health care platform CAZZLE

Lotte Healthcare is entering the digital health care market with the launch of CAZZLE, the company said Thursday. CAZZLE is a personalized health care platform that aims to provide easy health management, the health care subsidiary of Lotte Group said.

Baek Byung-yeul | 2023-09-14 15:31

Samsung Biologics invests in local antibody drug conjugate developer

Samsung Biologics invests in local antibody drug conjugate developer

Samsung Biologics invested in AimedBio, a local biotech company specialized in antibody-drug conjugates (ADCs), in a bid to expand into the next-generation drug business, the company said Wednesday.

Baek Byung-yeul | 2023-09-13 15:14

SK bioscience inks deal with Australian firm to develop patch-type typhoid vaccine

SK bioscience inks deal with Australian firm to develop patch-type typhoid vaccine

SK bioscience said Thursday it has reached a deal with Vaxxas, an Australian biotechnology company, to jointly develop a new patch-type typhoid vaccine.

2023-08-24 14:05

SK bioscience aims to boost competence with cell-based flu vaccine

SK bioscience aims to boost competence with cell-based flu vaccine

ANDONG - SK bioscience's L HOUSE plant in Andong, 270 kilometers southeast of Seoul, played a key role in protecting lives during the pandemic by producing COVID-19 vaccines. The Korean vaccine maker said Tuesday that sales of its SKYCellflu influenza vaccine began in Korea, Wednesday.

Baek Byung-yeul | 2023-08-23 16:36

Genome and Company aims to sell cancer drug candidates

Genome and Company aims to sell cancer drug candidates

Genome and Company is aiming to sell its drug candidates for targeted anti-cancer drugs to an overseas biopharmaceutical company within the year in a bid to become a company that develops both anti-cancer drugs and microbiome drugs, the CEO of the local biotech company said, Monday.

Baek Byung-yeul | 2023-08-21 16:48

Celltrion to merge with Celltrion Healthcare, Celltrion Pharm in 2 phases

Celltrion to merge with Celltrion Healthcare, Celltrion Pharm in 2 phases

Celltrion, a biosimilar producer, will merge with Celltrion Healthcare, a group subsidiary responsible for marketing biosimilar and other medicines, this year to create business synergy, Celltrion Group Chairman Seo Jung-jin said Thursday.

Baek Byung-yeul | 2023-08-17 19:42

1 2 3 4 5 6 7 8 9 10

Top 10 Stories

1	Methods to avoid YouTube, Netflix restrictions go viral

2	Anti-dog meat legislation looks doomed as Assembly session ends in vain

3	N. Korea's fear of external info grows after Seoul allows sending propaganda leaflets

4	Hunting 'crow thief' on Korea's east coast in 1930s

5	Leaders of Samsung, SK to visit Netherlands for chip alliance

6	Skepticism mounts over shareholder activism at Samsung C&T

7	Calls grow for shift from two-party political system

8	Eximbank teams up with US counterpart on decarbonization

9	'New initiative on NK' lacks balanced strategy: experts

10	Gov't boosts reserves to appease public jitters over urea shortage

DARKROOM